GlaxoSmithKline to divest US rights for Wellbutrin XL® to Biovail for $510 million

AstraZeneca pens $2.1B Sino deal for challenger to Merck’s COPD drug Ohtuvayre

Germany’s Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne Deal

STAT+: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms

Cancer therapy spinout Myricx Bio agrees to US$1.5B acquisition by Novartis

Myricx Bio, a cancer therapy spinout from the Francis Crick Institute and Imperial College London, has agreed to be acquired by Novartis in

Novartis to pay $1.1B upfront for UK biotech Myricx to expand the pharma's ADC pipeline

Abivax Aktie: 1.691 Prozent in zwölf Monaten